AARD vs PG · $284.4M cap vs P/E 25, rev $84.28B
Aardvark Therapeutics, Inc. Common Stock (AARD) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
Aardvark Therapeutics, Inc. Common Stock (AARD) is a biotechnology company listed on US.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
AARD does not have a complete income-statement cache yet.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
AARD currently screens at market cap $284.4M. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the AARD and PG stock pages for the full models.
Not investment advice.